miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
about
The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genesBody fluid biomarkers in Alzheimer's diseaseInvolvement of microRNA in microglia-mediated immune responseRegulation of TGF-β Signal TransductionA blood based 12-miRNA signature of Alzheimer disease patientsAge- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET.miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinomaLong non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancerWidespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.Epigenetic regulation of adult neural stem cells: implications for Alzheimer's disease.NMDA mediated contextual conditioning changes miRNA expressionDab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling.The microRNA cluster miR-106b~25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation.The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?Circulating microRNAs as a Fingerprint for Liver Cirrhosis.miRNA and miRNA target genes in copy number variations occurring in individuals with intellectual disability.Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression.Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant.Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration.Regulation of TGF-β receptor activityThe Path to microRNA Therapeutics in Psychiatric and Neurodegenerative DisordersmiR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.The preclinical discovery of amyotrophic lateral sclerosis drugs.Alzheimer's disease models and functional genomics-How many needles are there in the haystack?MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone.MicroRNA Expression in the Glaucomatous RetinaNeurodegeneration the RNA wayNodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model.MicroRNAs as biomarkers of disease onset.The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.MicroRNAs -the next generation therapeutic targets in human diseases.MicroRNAs and Molecular Mechanisms of Neurodegeneration.MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer's Disease.TGF-β Signaling from Receptors to Smads.A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells.MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
P2860
Q26748969-BC961E9D-C483-403C-B671-3012FCB86202Q26799208-3F00B4F4-A720-48FF-B3B6-E9D4C58D93B5Q26830098-E519B79C-E101-483C-BEBB-ADCFDB71AAF2Q26851399-5981D3AE-5DD0-4A63-89CA-4DF1FEEE6461Q26996826-FEA88A6A-A300-4CF1-A848-7CCEDF4730EFQ27499741-330F46B0-2615-4C37-8A96-0FAF7E499667Q31138018-D377646B-DACE-43D9-B41B-39A07FA6798DQ33661028-D73262F1-C639-4DC8-AE48-B352F0615011Q33688531-F318FBD0-EFFC-41AB-A85D-E7AAAAA15C7AQ33738316-EFCCC11E-7FA6-4A44-ABA5-1A9471EF73DCQ33841944-482A1166-C34D-49D8-ABAC-0F2129E3D0FFQ34023915-3124F312-E5F4-4DC5-B6D8-EFF0744B3D30Q34096401-7641920C-391E-46C1-A37A-106706C6304BQ34169338-EB822457-1EAD-481F-9A4F-C14EF6F1135BQ34426210-AC99BC42-4765-4611-BC79-745DC64819DBQ34785428-6BB13928-55D1-4363-A47F-FD35FE3F754FQ34928893-680DCB3D-CD5A-44FF-8F84-B7F87F24EDFAQ35111407-7F297910-68A1-48DD-B579-8A7F7826780FQ35405370-FFC3D423-CE33-44BF-BC35-B960D3A5EDC9Q35853304-32979CBE-8DAE-45B6-B255-02BAFFB14E32Q35875886-69ADDFC8-1605-4400-842C-A0C3ABE2411AQ35905598-75F788D1-3448-4FE3-9853-FAAA206FF836Q35966911-4707E760-3B1C-4C67-9D45-F6B6F1E6CEF7Q35970092-7F63B620-2B1D-4633-A670-D494A7322B8EQ36009915-D450790E-6CAC-4DB0-A89F-6E6A31358026Q36193841-09EDF687-AD15-440F-A6A0-99806E7BFF87Q36326306-3D941810-7012-431E-8112-914169E1809DQ36384654-33A7A408-9C91-4935-8945-410F5246AEF0Q36638284-FAED0DA6-D960-4FD5-9957-AA6EE76A6313Q37261529-5C93C9EB-9996-4BEF-97FB-35482DF10F16Q37872226-B5F600E9-0A92-4865-88F1-C7ADF64811A5Q37896029-AE0D76C8-9712-4DB9-B938-C343A6BF8B09Q38176359-AE664A9E-AC8B-4712-BB00-6A695717EE62Q38202497-2012A155-A903-4766-AA9B-67640CFCEBCCQ38261708-BF882413-1A0C-4AD7-9912-08A8B65FC244Q38637798-D32A464D-2CDD-4237-98A7-FE123100EE69Q38906099-F17DB456-5EDB-438F-A1E9-6CDC1FCB989BQ38927615-5219CB24-2E1A-4DB1-96DF-F5BD9100E78DQ39051588-F2B58490-B566-45B9-B47B-655C57E88536Q39069313-27E79BD5-B435-4B96-BC72-40A7DA12D786
P2860
miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
miR-106b aberrantly expressed ...... argets TGF-β type II receptor.
@en
miR-106b aberrantly expressed ...... argets TGF-β type II receptor.
@nl
type
label
miR-106b aberrantly expressed ...... argets TGF-β type II receptor.
@en
miR-106b aberrantly expressed ...... argets TGF-β type II receptor.
@nl
prefLabel
miR-106b aberrantly expressed ...... argets TGF-β type II receptor.
@en
miR-106b aberrantly expressed ...... argets TGF-β type II receptor.
@nl
P2093
P1433
P1476
miR-106b aberrantly expressed ...... argets TGF-β type II receptor.
@en
P2093
Chunmei Ma
Hailin Wang
Jialin Liu
Lianfeng Zhang
Yanfeng Xu
P304
P356
10.1016/J.BRAINRES.2010.08.023
P407
P577
2010-08-13T00:00:00Z